JAMA Ophthalmology
Scope & Guideline
Empowering Global Collaboration in Ophthalmology
Introduction
Aims and Scopes
- Research on Eye Diseases and Disorders:
The journal publishes studies on various ocular conditions, including glaucoma, diabetic retinopathy, age-related macular degeneration, and inherited retinal diseases, focusing on their pathophysiology, diagnosis, and treatment. - Clinical Trials and Therapeutic Interventions:
JAMA Ophthalmology features randomized clinical trials assessing the efficacy and safety of new therapies, surgical techniques, and interventions in managing ocular diseases. - Public Health and Epidemiology:
The journal addresses the impact of social determinants on eye health, exploring disparities in access to care, prevalence of eye diseases, and public health initiatives aimed at improving ocular health. - Innovations in Ophthalmic Technology:
Research on advancements in imaging technologies, artificial intelligence applications, and telemedicine in ophthalmology is a significant focus, highlighting their role in enhancing diagnosis and treatment. - Genetic and Molecular Studies:
Studies investigating genetic factors related to eye diseases, including genetic mutations and biomarkers, are central to the journal's scope, contributing to personalized medicine in ophthalmology. - Patient-Centered Research:
Research emphasizing the experiences and perspectives of patients, including quality of life assessments and the psychosocial impact of ocular diseases, is an important component of the journal's aims.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
The integration of AI and machine learning in diagnosing and managing ocular diseases is a rapidly growing focus, with numerous studies exploring its application in retinal imaging and predictive analytics. - Telemedicine and Remote Care:
The COVID-19 pandemic has accelerated the adoption of telemedicine in ophthalmology, leading to an increase in research on remote monitoring, virtual consultations, and their effectiveness. - Health Equity and Social Determinants of Health:
There is a growing emphasis on understanding and addressing disparities in eye care access and outcomes, with studies focusing on the influence of socioeconomic and demographic factors. - Gene Therapy and Genetic Research:
Emerging research on gene therapy for inherited retinal diseases and the role of genetic testing in personalized treatment plans is gaining traction, reflecting advancements in molecular medicine. - Patient-Centered Outcomes and Quality of Life:
Research that emphasizes the importance of patient-reported outcomes, satisfaction, and quality of life in managing ocular diseases is becoming increasingly prevalent.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decrease in the publication of studies focusing on conventional surgical methods as more emphasis is placed on minimally invasive techniques and technological advancements. - General Ophthalmology Topics:
Research covering broad or general topics in ophthalmology is waning, with more specialized and targeted studies gaining traction, reflecting a shift towards precision medicine. - Pharmacological Interventions without Novelty:
Papers discussing established pharmacological treatments without new insights or comparative studies are less frequently accepted, indicating a preference for novel therapeutic approaches. - Non-Evidence-Based Practices:
The journal appears to be moving away from studies that do not employ rigorous evidence-based methodologies, favoring those that provide stronger scientific validation.
Similar Journals
EXPERIMENTAL EYE RESEARCH
Advancing Vision Science Through Innovative ResearchEXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.
BRITISH JOURNAL OF OPHTHALMOLOGY
Pioneering Discoveries in Ocular ScienceThe British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.
BMC Ophthalmology
Pioneering Discoveries in Eye Health and TreatmentBMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.
International Journal of Ophthalmology
Pioneering Discoveries in Eye Care and TreatmentThe International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.
Translational Vision Science & Technology
Exploring New Horizons in Eye Health and TechnologyTranslational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.
Augenheilkunde Up2date
Enhancing Expertise in Vision Science.Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.
OPHTHALMOLOGICA
Connecting Disciplines to Enhance Vision CareOPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
Empowering the global community with groundbreaking findings.ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.
OPHTHALMIC EPIDEMIOLOGY
Illuminating Insights in Ocular EpidemiologyOphthalmic Epidemiology, published by Taylor & Francis Inc, stands as a crucial platform in the fields of ophthalmology and epidemiology, with the journal's pivotal contributions recognized in its esteemed category quartiles, ranking Q1 in Ophthalmology and Q2 in Epidemiology for 2023. Since its inception in 1994, the journal has provided a multidisciplinary approach to understanding the distribution and determinants of ocular diseases, thereby informing public health practices and clinical interventions. With a commitment to disseminating high-impact research, it holds a Scopus rank of #45/137 in Ophthalmology and engages a global audience of researchers, practitioners, and students dedicated to advancing the field. Although it is not an open-access journal, Ophthalmic Epidemiology remains a vital resource for innovative studies and reviews that help shape evidence-based strategies to combat vision-related public health issues.
Asia-Pacific Journal of Ophthalmology
Illuminating the future of ophthalmology in the Asia-Pacific.Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.